DeepMed Research

THOMAS JEFFERSON UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1824-01-01

Employees: 10K

Market Cap: -

Website: http://www.jefferson.edu

Clinical Trials

Linguistically-Tailored Mobile Intervention for the Improvement of Follow Up for Abnormal Pap Test Results

Not Applicable

Completed

Conditions: Cervical Carcinoma

Interventions: Other: Health Promotion and Education
Other: Survey Administration
Other: Interview

First Posted Date: 2021-03-29

Last Posted Date: 2025-04-29

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 30

Registration Number: NCT04821297

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Ropivacaine Pharmacokinetics in ESP Blocks

Conditions: Local Anesthetic Systemic Toxicity
Pain
Quality of Recovery

First Posted Date: 2021-03-19

Last Posted Date: 2022-06-06

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 20

Registration Number: NCT04807504

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

NuroSleeve Powered Brace & Stimulation System to Restore Arm Function

Not Applicable

Active, not recruiting

Conditions: Spinal Cord Injuries
Cerebral Palsy
Hemiparesis
Quadriplegia
Weakness of Extremities as Sequela of Stroke
Muscular Dystrophies
Stroke
Weakness Due to Upper Motor Neuron Dysfunction
Amyotrophic Lateral Sclerosis
Neurologic Diseases

Interventions: Device: Neurosleeve

First Posted Date: 2021-03-15

Last Posted Date: 2025-04-09

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 20

Registration Number: NCT04798378

Locations: 🇺🇸
Nemours Children's Hospital, Wilmington, Delaware, United States
🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Geriatric Assessment Screening Tool for the Identification of At-Risk Older Adults Who Are Undergoing Cancer Treatment

Not Applicable

Completed

Conditions: Hematopoietic and Lymphoid Cell Neoplasm
Malignant Solid Neoplasm

Interventions: Other: Educational Intervention
Other: Screening Questionnaire Administration
Other: Referral
Other: Questionnaire Administration

First Posted Date: 2021-03-09

Last Posted Date: 2025-04-29

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 76

Registration Number: NCT04788758

Locations: 🇺🇸
Thomas Jefefrson University, Philadelphia, Pennsylvania, United States

Enhanced Genetic Awareness and Genetic Evaluation for Men Through Technology, ENGAGEMENT Study

Active, not recruiting

Conditions: Prostate Carcinoma

Interventions: Other: Educational Intervention
Other: Survey Administration
Other: Interview

First Posted Date: 2021-03-09

Last Posted Date: 2025-01-03

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 118

Registration Number: NCT04789018

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Detection of Prostate Cancer Using Voided Urine

Recruiting

Conditions: Prostate Carcinoma

Interventions: Procedure: Biospecimen Collection

First Posted Date: 2021-03-09

Last Posted Date: 2024-06-27

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 675

Registration Number: NCT04788277

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Exercise Training and Behavioral Modification for the Improvement of Physical Activity in Head and Neck Cancer Patients Undergoing Cancer Treatment

Not Applicable

Completed

Conditions: Oral Cavity Carcinoma
Sinonasal Carcinoma
Stage IV Laryngeal Cancer AJCC v8
Stage IVB Laryngeal Cancer AJCC v8
Stage IVC Laryngeal Cancer AJCC v8
Laryngeal Carcinoma
Maxillary Sinus Carcinoma
Head and Neck Carcinoma
Hypopharyngeal Carcinoma
Oropharyngeal Carcinoma

Interventions: Other: Medical Device Usage and Evaluation
Other: Consultation
Other: Exercise Intervention
Behavioral: Behavioral Intervention
Other: Questionnaire Administration
Other: Quality of Life Assessment

First Posted Date: 2021-03-09

Last Posted Date: 2025-05-22

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 12

Registration Number: NCT04788264

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Transfer of Infection Fighting Immune Cells Generated in the Laboratory to High Risk Patients With COVID-19 Infection

Phase 1

Completed

Conditions: Covid19

Interventions: Drug: Cytotoxic T Lymphocytes

First Posted Date: 2021-02-21

Last Posted Date: 2025-04-29

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 30

Registration Number: NCT04765449

Locations: 🇺🇸
Thomas Jefferson University, Philadelphia, Pennsylvania, United States

Pharmacokinetics of Progesterone in Pregnancy-2

Phase 1

Terminated

Conditions: Pregnancy Related

Interventions: Drug: micronized Progesterone

First Posted Date: 2021-02-15

Last Posted Date: 2022-05-26

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 3

Registration Number: NCT04753957

Locations: 🇺🇸
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, United States

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Phase 2

Active, not recruiting

Conditions: Metastatic Malignant Neoplasm in the Liver
Metastatic Uveal Melanoma
Stage IV Choroidal and Ciliary Body Melanoma AJCC V8

Interventions: Drug: Carmustine
Drug: Ethiodized Oil
Procedure: Transarterial Chemoembolization
Other: Medical Device Usage and Evaluation

First Posted Date: 2021-01-28

Last Posted Date: 2025-02-10

Lead Sponsor: Thomas Jefferson University

Target Recruit Count: 28

Registration Number: NCT04728633

Locations: 🇺🇸
Sidney Kimmel Cancer Center at Thomas Jefferson Univeristy, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy